369 related articles for article (PubMed ID: 23250910)
1. MiR-124 targets Slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer.
Liang YJ; Wang QY; Zhou CX; Yin QQ; He M; Yu XT; Cao DX; Chen GQ; He JR; Zhao Q
Carcinogenesis; 2013 Mar; 34(3):713-22. PubMed ID: 23250910
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
Xu Q; Sun Q; Zhang J; Yu J; Chen W; Zhang Z
Carcinogenesis; 2013 Mar; 34(3):539-49. PubMed ID: 23188671
[TBL] [Abstract][Full Text] [Related]
3. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
4. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30a increases tight junction protein expression to suppress the epithelial-mesenchymal transition and metastasis by targeting Slug in breast cancer.
Chang CW; Yu JC; Hsieh YH; Yao CC; Chao JI; Chen PM; Hsieh HY; Hsiung CN; Chu HW; Shen CY; Cheng CW
Oncotarget; 2016 Mar; 7(13):16462-78. PubMed ID: 26918943
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties.
Tominaga E; Yuasa K; Shimazaki S; Hijikata T
Exp Cell Res; 2013 Feb; 319(3):77-88. PubMed ID: 23142026
[TBL] [Abstract][Full Text] [Related]
7. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
[TBL] [Abstract][Full Text] [Related]
8. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
9. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.
Lambertini E; Lolli A; Vezzali F; Penolazzi L; Gambari R; Piva R
BMC Cancer; 2012 Oct; 12():445. PubMed ID: 23031797
[TBL] [Abstract][Full Text] [Related]
12. MiR-630 suppresses breast cancer progression by targeting metadherin.
Zhou CX; Wang CL; Yu AL; Wang QY; Zhan MN; Tang J; Gong XF; Yin QQ; He M; He JR; Chen GQ; Zhao Q
Oncotarget; 2016 Jan; 7(2):1288-99. PubMed ID: 26595523
[TBL] [Abstract][Full Text] [Related]
13. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
14. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
Kumarswamy R; Mudduluru G; Ceppi P; Muppala S; Kozlowski M; Niklinski J; Papotti M; Allgayer H
Int J Cancer; 2012 May; 130(9):2044-53. PubMed ID: 21633953
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.
Kuo TC; Tan CT; Chang YW; Hong CC; Lee WJ; Chen MW; Jeng YM; Chiou J; Yu P; Chen PS; Wang MY; Hsiao M; Su JL; Kuo ML
J Clin Invest; 2013 Mar; 123(3):1082-95. PubMed ID: 23434592
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
Huang J; Yao X; Zhang J; Dong B; Chen Q; Xue W; Liu D; Huang Y
Cancer Sci; 2013 Dec; 104(12):1609-17. PubMed ID: 24112779
[TBL] [Abstract][Full Text] [Related]
18. SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.
Hahn S; Jackstadt R; Siemens H; Hünten S; Hermeking H
EMBO J; 2013 Nov; 32(23):3079-95. PubMed ID: 24185900
[TBL] [Abstract][Full Text] [Related]
19. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
[TBL] [Abstract][Full Text] [Related]
20. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Ahmad A; Aboukameel A; Kong D; Wang Z; Sethi S; Chen W; Sarkar FH; Raz A
Cancer Res; 2011 May; 71(9):3400-9. PubMed ID: 21389093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
